Acanthamoeba Keratitis

Overview & Microbiology

Acanthamoeba is a genus of free-living protozoa, not a bacterium, fungus, or virus, and it is ubiquitous in soil, dust, tap water, swimming pools, and hot tubs. Most infectious keratitides are opportunists, needing a compromised host or a break in the epithelium to take hold. Acanthamoeba is different: it is a competent pathogen in its own right and can establish infection even in an eye with an otherwise intact ocular surface.

The organism's defining biological feature is a two-stage life cycle, and it explains almost everything difficult about managing this disease. Under favorable conditions, Acanthamoeba exists as an actively feeding, replicating trophozoite. When conditions turn hostile (desiccation, extreme temperature, low nutrients, or exposure to disinfectants and antimicrobial drugs), it transforms into a dormant cyst protected by a resistant double wall, part of which is composed of cellulose. That double wall lets the cyst survive disinfection regimens, chlorinated water, and antimicrobial concentrations that would kill the trophozoite outright, and it can revert to an active trophozoite once conditions improve again. A treatment course that clears every trophozoite but leaves a single viable cyst behind sets up a relapse. This is why antiamoebic therapy has to run for months, not weeks.

Risk Factors

The overwhelming majority of cases occur in contact lens wearers, and trace back specifically to water exposure while lenses are in the eye: swimming, showering, or sitting in a hot tub with lenses in, or rinsing lenses or a lens case with tap water instead of proper disinfecting solution. Homemade or diluted saline solutions, and "topping off" old solution instead of fully replacing it, are also well-documented risk factors, since none of these practices reliably kill Acanthamoeba cysts the way a proper multipurpose or hydrogen-peroxide disinfecting system is formulated to. (See the sibling Contact Lens-Related Corneal Disease page for the broader contact-lens-hygiene risk picture; this page focuses on the organism itself.) Non-lens-wearers can still develop the disease after corneal trauma involving contaminated water or soil, though this is far less common.

Clinical Features

Early Acanthamoeba keratitis is a diagnostic trap. Its earliest signs (punctate epithelial changes, mild haze, a nonspecific epitheliitis) closely resemble herpes simplex epithelial disease. The single most useful clue at this stage is a symptom rather than a sign: pain markedly out of proportion to the modest findings on slit-lamp exam. This disproportionate pain is thought to arise from radial perineural infiltration of the corneal nerves by the organism, and it is why so many early cases are initially treated as herpetic keratitis before the diagnosis is reconsidered.

A more specific, though often late-appearing, sign is radial keratoneuritis: perineural infiltrates tracking along corneal nerve fibers, a direct correlate of the pain pattern above. As disease progresses, a classic but late finding is the ring infiltrate, a circular, annular stromal infiltrate that represents an immune-mediated host response to Acanthamoeba antigens rather than the organism burden itself. Waiting for the ring infiltrate to appear before considering the diagnosis means losing the window where treatment is easiest.

Diagnosis

In vivo confocal microscopy is the key bedside diagnostic tool: it provides real-time, non-invasive, cellular-resolution imaging that can directly visualize the double-walled cysts within the corneal stroma without a biopsy, making it the fastest way to confirm the diagnosis in a patient already in front of you.

On a corneal scraping, calcofluor white stain is the most useful staining technique. It binds the polysaccharide (chitin/cellulose) components of the cyst wall, causing the cysts to fluoresce brightly under fluorescence microscopy, a rapid and sensitive way to confirm cysts on a smear when confocal microscopy isn't available or the clinical picture needs pathologic confirmation. Culture on non-nutrient agar overlaid with E. coli remains the traditional definitive method, but it is slower to result than either confocal imaging or calcofluor staining.

Treatment

First-line therapy combines a biguanide (polyhexamethylene biguanide/PHMB, or chlorhexidine) with a diamidine (propamidine isethionate, or hexamidine). The two drug classes act on different structures of the organism, targeting both the trophozoite and, critically, the cyst wall, which is why they are used in combination rather than as monotherapy.

No drug regimen is guaranteed to eliminate every cyst on the first pass, and a single surviving cyst can revert to an active trophozoite and repopulate the infection. Treatment courses are therefore prolonged, commonly extending for months, with a slow taper only once clinical and (where available) confocal evidence of clearance is sustained. Topical corticosteroids are used cautiously if at all in active disease: suppressing the host immune response can give the organism more room to proliferate. When the diagnosis is missed early and a patient is empirically started on steroids for presumed herpetic or inflammatory disease, the infection can accelerate.

High-Yield Pearls

• Trophozoite (active, feeding) vs. cyst (dormant, double-walled, resistant): the cyst form is why treatment courses run for months, not weeks.
• Classic exposure history: contact lens wear plus tap water exposure, such as swimming, showering, homemade saline, or topping off solution instead of replacing it.
• Pain out of proportion to exam findings is the earliest and most useful clinical clue; the ring infiltrate is real but comes late.
• Confocal microscopy for bedside cyst visualization; calcofluor white stain on a corneal scraping for pathologic confirmation.
• Treatment is combination biguanide + diamidine, prolonged for months because of cyst resistance to a single drug or a short course.

Related Topics

Continue exploring Cornea & External Disease: